NO20055601L - Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer - Google Patents

Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer

Info

Publication number: NO20055601L
Authority: NO; Norway
Prior art keywords: hydrogel; active ingredients; pharmaceutical preparation; transdermal administration; active ingredient
Prior art date: 2003-04-28

Application number

NO20055601A

Other languages

English (en)

Norwegian (no)

Other versions

NO20055601D0 (no

Inventor

Patrick Franke

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-28

Filing date

2005-11-25

Publication date

2006-01-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33395772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055601(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-11-25 Application filed by Schering Ag filed Critical Schering Ag

2005-11-25 Publication of NO20055601D0 publication Critical patent/NO20055601D0/no

2006-01-26 Publication of NO20055601L publication Critical patent/NO20055601L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Oil, Petroleum & Natural Gas (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gynecology & Obstetrics (AREA)
Neurology (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

NO20055601A 2003-04-28 2005-11-25 Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer NO20055601L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03008856		2003-04-28
PCT/EP2004/004224 WO2004096191A1 (de)	2003-04-28	2004-04-21	Pharmazeutische zusammensetzung in form eines hydrogels zur transdermalen verabreichung von wirkstoffen

Publications (2)

Publication Number	Publication Date
NO20055601D0 NO20055601D0 (no)	2005-11-25
NO20055601L true NO20055601L (no)	2006-01-26

Family

ID=33395772

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055601A NO20055601L (no)	2003-04-28	2005-11-25	Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer

Country Status (32)

Country	Link
EP (2)	EP1875905B1 (pl)
JP (2)	JP4829102B2 (pl)
KR (1)	KR101093999B1 (pl)
CN (1)	CN1780610B (pl)
AR (1)	AR044113A1 (pl)
AT (2)	ATE467412T1 (pl)
AU (1)	AU2004233572B2 (pl)
BR (1)	BRPI0409918A (pl)
CA (1)	CA2523734C (pl)
CL (1)	CL2004000884A1 (pl)
CO (1)	CO5640075A2 (pl)
CR (1)	CR8059A (pl)
CY (1)	CY1108069T1 (pl)
DE (2)	DE502004006196D1 (pl)
DK (1)	DK1617827T3 (pl)
EA (1)	EA008686B1 (pl)
EC (1)	ECSP056186A (pl)
ES (2)	ES2345458T3 (pl)
HR (1)	HRP20080178T3 (pl)
JO (1)	JO2492B1 (pl)
MX (1)	MXPA05011541A (pl)
NO (1)	NO20055601L (pl)
NZ (2)	NZ543264A (pl)
PE (1)	PE20050461A1 (pl)
PL (1)	PL1617827T3 (pl)
PT (1)	PT1617827E (pl)
RS (1)	RS51307B (pl)
SI (1)	SI1617827T1 (pl)
TW (1)	TWI343259B (pl)
UA (1)	UA83036C2 (pl)
WO (1)	WO2004096191A1 (pl)
ZA (1)	ZA200509549B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0506139D0 (en) *	2005-03-24	2005-05-04	Transphase Ltd	A transdermal topical composition and its uses
GB0506141D0 (en) *	2005-03-24	2005-05-04	Transphase Ltd	A topical compostion and its uses
DE102005015128B4 (de) *	2005-03-31	2008-12-11	Bayer Schering Pharma Aktiengesellschaft	Wafer enthaltend Steroidhormone
DE102005035879A1 (de) *	2005-07-30	2007-02-01	Paul Hartmann Ag	Hydrogel
SE536091C2 (sv) *	2011-04-14	2013-04-30	Pep Tonic Medical Ab	Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
JP5934781B2 (ja) *	2011-04-25	2016-06-15	パーク、ジュン−ヒョン	脱毛防止及び発毛促進用外用剤組成物
FR2976808B1 (fr) *	2011-06-22	2013-06-28	Urgo Lab	Composition filmogene et son utilisation pour le traitement de l'herpes
US9855211B2 (en) *	2013-02-28	2018-01-02	Novan, Inc.	Topical compositions and methods of using the same
DE102018213754A1 (de) *	2018-08-15	2020-02-20	Henkel Ag & Co. Kgaa	"Tris(hydroxymethyl-)aminomethan oder seine Salze als Wirkstoff zur Reduzierung der Schweißsekretion“

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1182229B (de)	1960-11-16	1964-11-26	Upjohn Co	Verfahren zur Herstellung von 7-Methylsteroiden
US3341557A (en)	1961-06-05	1967-09-12	Upjohn Co	7-methyltestosterones
US3924004A (en)	1971-11-24	1975-12-02	Syntex Corp	Fatty alcohol-propylene carbonate-glycol solvent cream vehicle
US4000273A (en)	1973-11-01	1976-12-28	Richardson-Merrell Inc.	Method for the control of fertility
JPS5540604A (en) *	1978-09-14	1980-03-22	Mitsui Toatsu Chem Inc	Improved local topicum
FR2518879A1 (fr) *	1981-12-30	1983-07-01	Besins Jean	Medicament a base d'oestradiol pour le traitement de la pathologie menopausique
JPS5970612A (ja)	1982-10-13	1984-04-21	Nippon Redarii Kk	ゲル軟膏基剤
JPH01503281A (ja) *	1987-05-27	1989-11-09	ブルグハルト，クルト	経皮治療に有効な医薬包帯剤およびこれを施用するためのデバイス
EP0394429B1 (de) *	1988-10-27	1996-01-10	Schering Aktiengesellschaft	Mittel zur transdermalen applikation enthaltend gestoden
WO1993025168A1 (en) *	1992-06-11	1993-12-23	Theratech, Inc.	The use of glycerin in moderating transdermal drug delivery
US5460620A (en) *	1992-07-31	1995-10-24	Creative Products Resource, Inc.	Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
AU3723695A (en)	1994-09-14	1996-03-29	Minnesota Mining And Manufacturing Company	Transdermal device for delivery of levonorgestrel
FR2732223B1 (fr)	1995-03-30	1997-06-13	Sanofi Sa	Composition pharmaceutique pour administration transdermique
DE19526864A1 (de)	1995-07-22	1997-01-23	Labtec Gmbh	Hormonpflaster
JPH09194396A (ja)	1996-01-17	1997-07-29	Pola Chem Ind Inc	貼付剤用マトリックス
US5733565A (en)	1996-02-23	1998-03-31	The Population Council, Center For Biomedical Research	Male contraceptive implant
KR970064620A (ko) *	1996-03-05	1997-10-13	임성기	사이클로스포린-함유 외용약제 조성물
US5736128A (en) *	1996-05-14	1998-04-07	Isp Investments Inc.	Cosmetic composition for rejuvenation of skin without skin irritation
AU3136897A (en)	1996-05-22	1997-12-09	Diversified Pharmaceuticals, Inc.	Compositions, methods and devices for the transdermal delivery of drugs
IT1283102B1 (it) *	1996-06-06	1998-04-07	Permatec Nv	Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
US5993787A (en)	1996-09-13	1999-11-30	Johnson & Johnson Consumer Products, Inc.	Composition base for topical therapeutic and cosmetic preparations
US6767902B2 (en)	1997-09-17	2004-07-27	The Population Council, Inc.	Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en)	1997-09-17	2002-01-31	Alfred J. Moo-Young	Transdermal administration of ment
WO1999067271A1 (en)	1998-06-19	1999-12-29	Akzo Nobel N.V.	Testosterone derivative
FR2781666B1 (fr) *	1998-07-30	2000-09-08	Oreal	Composition cosmetique solide et ses utilisations
JP2935113B1 (ja) *	1998-09-24	1999-08-16	小林製薬株式会社	インドメタシン経皮吸収剤
JP2000264899A (ja) *	1999-01-13	2000-09-26	Taisho Pharmaceut Co Ltd	ステロイド外用剤
AU2003600A (en)	1999-01-13	2000-08-01	Taisho Pharmaceutical Co., Ltd.	External steroid preparation
JP2001139451A (ja) *	1999-11-17	2001-05-22	Lion Corp	ジェル状化粧料
CN1481388A (zh)	2000-12-15	2004-03-10	��˹��ŵ��	具有雄激素-孕激素混合活性的14(15)-不饱和的15-和/或16-取代的雄激素类
DE10104327A1 (de) *	2001-01-24	2002-07-25	Schering Ag	11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
DE10107663B4 (de)	2001-02-19	2004-09-09	Lts Lohmann Therapie-Systeme Ag	Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung

2004
- 2004-03-25 JO JO200439A patent/JO2492B1/en active
- 2004-04-19 TW TW093110876A patent/TWI343259B/zh not_active IP Right Cessation
- 2004-04-21 PL PL04728563T patent/PL1617827T3/pl unknown
- 2004-04-21 HR HR20080178T patent/HRP20080178T3/xx unknown
- 2004-04-21 NZ NZ543264A patent/NZ543264A/en not_active IP Right Cessation
- 2004-04-21 EA EA200501583A patent/EA008686B1/ru not_active IP Right Cessation
- 2004-04-21 UA UAA200511102A patent/UA83036C2/ru unknown
- 2004-04-21 DE DE502004006196T patent/DE502004006196D1/de not_active Expired - Lifetime
- 2004-04-21 RS YUP-2005/0809A patent/RS51307B/sr unknown
- 2004-04-21 WO PCT/EP2004/004224 patent/WO2004096191A1/de not_active Ceased
- 2004-04-21 AU AU2004233572A patent/AU2004233572B2/en not_active Ceased
- 2004-04-21 EP EP07075742A patent/EP1875905B1/de not_active Expired - Lifetime
- 2004-04-21 ES ES07075742T patent/ES2345458T3/es not_active Expired - Lifetime
- 2004-04-21 AT AT07075742T patent/ATE467412T1/de active
- 2004-04-21 JP JP2006505217A patent/JP4829102B2/ja not_active Expired - Fee Related
- 2004-04-21 EP EP04728563A patent/EP1617827B1/de not_active Expired - Lifetime
- 2004-04-21 NZ NZ583760A patent/NZ583760A/en unknown
- 2004-04-21 KR KR1020057020394A patent/KR101093999B1/ko not_active Expired - Fee Related
- 2004-04-21 ES ES04728563T patent/ES2300763T3/es not_active Expired - Lifetime
- 2004-04-21 CA CA002523734A patent/CA2523734C/en not_active Expired - Fee Related
- 2004-04-21 BR BRPI0409918-4A patent/BRPI0409918A/pt not_active IP Right Cessation
- 2004-04-21 AT AT04728563T patent/ATE385786T1/de active
- 2004-04-21 DK DK04728563T patent/DK1617827T3/da active
- 2004-04-21 DE DE502004011164T patent/DE502004011164D1/de not_active Expired - Lifetime
- 2004-04-21 CN CN2004800114045A patent/CN1780610B/zh not_active Expired - Fee Related
- 2004-04-21 PT PT04728563T patent/PT1617827E/pt unknown
- 2004-04-21 SI SI200430685T patent/SI1617827T1/sl unknown
- 2004-04-21 MX MXPA05011541A patent/MXPA05011541A/es active IP Right Grant
- 2004-04-26 PE PE2004000409A patent/PE20050461A1/es not_active Application Discontinuation
- 2004-04-27 CL CL200400884A patent/CL2004000884A1/es unknown
- 2004-04-28 AR ARP040101436A patent/AR044113A1/es unknown
2005
- 2005-10-24 CR CR8059A patent/CR8059A/es unknown
- 2005-11-24 ZA ZA200509549A patent/ZA200509549B/en unknown
- 2005-11-25 CO CO05119657A patent/CO5640075A2/es not_active Application Discontinuation
- 2005-11-25 NO NO20055601A patent/NO20055601L/no not_active Application Discontinuation
- 2005-11-25 EC EC2005006186A patent/ECSP056186A/es unknown
2008
- 2008-05-13 CY CY20081100503T patent/CY1108069T1/el unknown
2010
- 2010-07-02 JP JP2010152291A patent/JP2010241824A/ja active Pending

Also Published As

Publication number	Publication date
ES2345458T3 (es)	2010-09-23
EA200501583A1 (ru)	2006-06-30
DK1617827T3 (da)	2008-06-02
JP2010241824A (ja)	2010-10-28
RS51307B (sr)	2010-12-31
WO2004096191A1 (de)	2004-11-11
AU2004233572B2 (en)	2010-07-15
JP4829102B2 (ja)	2011-12-07
AU2004233572A1 (en)	2004-11-11
NZ543264A (en)	2010-03-26
DE502004011164D1 (de)	2010-06-24
MXPA05011541A (es)	2006-05-31
CN1780610B (zh)	2010-06-09
NO20055601D0 (no)	2005-11-25
EP1617827A1 (de)	2006-01-25
ATE467412T1 (de)	2010-05-15
PL1617827T3 (pl)	2008-07-31
EA008686B1 (ru)	2007-06-29
CL2004000884A1 (es)	2005-03-11
KR101093999B1 (ko)	2011-12-15
BRPI0409918A (pt)	2006-04-25
TW200524644A (en)	2005-08-01
EP1875905A2 (de)	2008-01-09
CO5640075A2 (es)	2006-05-31
ZA200509549B (en)	2007-02-28
NZ583760A (en)	2011-10-28
EP1875905B1 (de)	2010-05-12
ES2300763T3 (es)	2008-06-16
CY1108069T1 (el)	2014-02-12
SI1617827T1 (sl)	2008-06-30
JO2492B1 (en)	2009-10-05
DE502004006196D1 (de)	2008-03-27
CR8059A (es)	2006-05-29
CA2523734C (en)	2009-12-22
CN1780610A (zh)	2006-05-31
AR044113A1 (es)	2005-08-24
ATE385786T1 (de)	2008-03-15
EP1617827B1 (de)	2008-02-13
PT1617827E (pt)	2008-04-30
RS20050809A (sr)	2007-09-21
PE20050461A1 (es)	2005-08-13
UA83036C2 (ru)	2008-06-10
TWI343259B (en)	2011-06-11
CA2523734A1 (en)	2004-11-11
ECSP056186A (es)	2006-04-19
HRP20080178T3 (hr)	2008-05-31
EP1875905A3 (de)	2008-06-25
JP2006524653A (ja)	2006-11-02
KR20060007403A (ko)	2006-01-24
HK1087633A1 (zh)	2006-10-20

Publication	Publication Date	Title
US5807568A (en)	1998-09-15	Enhanced delivery of topical compositions containing flurbiprofen
CA2569121C (en)	2013-01-15	Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
SV2004001556A (es)	2004-03-08	Preparaciones acidas de insulina con establidad mejorada
US20050187212A1 (en)	2005-08-25	Pharmaceutical composition for topical delivery of meloxicam
ATE323473T1 (de)	2006-05-15	Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
AR057422A1 (es)	2007-12-05	Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma
AR037490A1 (es)	2004-11-17	Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
TW200815045A (en)	2008-04-01	Pharmaceutical compositions of ropinirole and methods of use thereof
BRPI0508933A (pt)	2007-08-14	composições para entrega tópica
WO2012087749A1 (en)	2012-06-28	Composition for transdermal administration of non-steroidal anti-inflammatory drug
WO2009004995A1 (ja)	2009-01-08	生理活性物質を定着および発現させる方法
DE60313359D1 (de)	2007-05-31	Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
AR061166A1 (es)	2008-08-06	Composiciones farmaceuticas para la liberacion sostenida de fenilferina
NO20073457L (no)	2007-09-05	Stabile sammensetninger av fenofibrat med fettsyreestere
NO20055601L (no)	2006-01-26	Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
CA2494473A1 (en)	2005-04-25	Stabilized protein compositions for topical administration and methods of making same
DK1305057T3 (da)	2005-10-24	Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse
DK1300143T3 (da)	2007-07-09	Plaster som indeholder 4-biphenyleddikesyre
KR20110053236A (ko)	2011-05-19	경피 투여용 조성물
KR101490708B1 (ko)	2015-02-09	록소프로펜 또는 그의 염을 포함하는 경피 흡수용 조성물및 이를 포함하는 경피 투여 첩부제
BRPI0506710A (pt)	2007-05-02	composições farmacêuticas de liberação controlada
CN102970974B (zh)	2015-03-04	用于治疗皮炎和牛皮癣的去炎松缩酮制剂
WO2025189162A1 (en)	2025-09-12	Topical delivery of epinephrine and prodrug compositions
AU2003264113A1 (en)	2004-03-29	Composition and use thereof as a pharmaceutical or cosmetic formulation for external application
TH69376A (th)	2005-06-28	สารผสมทางเภสัชกรรมในรูปของเจลน้ำสำหรับการให้ส่วนผสมที่มีฤทธิ์ต่างๆ ผ่านผิวหนัง

Legal Events

Date	Code	Title	Description
2012-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application